Never discontinue GLP-1 medication without medical guidance, as abrupt cessation may worsen glycaemic control or cause weight regain
Patients should avoid extended or repeated cycles unless continued treatment has been reviewed by a qualified provider
The evidence base supporting its use draws from studies on CJC-1295, Ipamorelin, and established GHRH/GHRP co-stimulation models, collectively informing research into pulsatile endocrine signaling, metabolic pathway regulation, and tissue-level responses under controlled experimental conditions
Doesnt Address the Root Issue Does Ozempic reduce insulin resistance
Exercise as a Secondary Metabolic Stressor Adipose tissue dysfunction in obesity promotes the release of small extracellular vesicles enriched with oxidatively stressed mitochondrial components [66, 91], reflecting unresolved mitochondrial strain